Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : SNRS- Sunrise Technologies -- Ignore unavailable to you. Want to Upgrade?

To: David Graham who wrote (766)	4/22/1998 12:12:00 AM
From: heidi medline	Read Replies (1) \| Respond to of 4140

Hi skane its me again. I read the article about the phase two trials. Could you or anybody else out there tell me the difference between the phase II and phase III trials. Is it just more people and both eyes at the same time. More importantly could anybody compare the results of 84% of people improving to 20/40 or better with no complications to the results of the visx laser. I know the visx laser treats myopia but the success rates. I am trying to get a feeling for what success rate is probably necessary for FDA approval. Thirdly do you know why it popped up to 10 3/8 in early trading. thanks very much.